Department of Post-Qualifying Healthcare Practice, Birmingham City University, Birmingham, UK.
Shenzhen Children's Hospital, Cardiothoracic Surgery Department, Shenzhen, China.
JPEN J Parenter Enteral Nutr. 2024 May;48(4):406-420. doi: 10.1002/jpen.2626. Epub 2024 Mar 30.
Enteral nutrition (EN) is one method of nutrition support for children and adolescents receiving extracorporeal membrane oxygenation (ECMO) therapy, and there are no guidelines for its use in this population. We conducted a systematic review to determine whether EN is effective and safe in children supported by ECMO. We searched the Cochrane Library database, MEDLINE, and Embase on Ovid in March 2023 to identify studies that evaluated children and adolescents who received ECMO and were treated with EN. Random effects meta-analysis was used to estimate the odds of mortality with EN compared with parenteral nutrition (PN). A total of 14 studies were included in this review with 1650 patients (796 received EN). The median duration of ECMO was 5-10 days, and the median EN initiation time ranged from 23 h to 7 days. The pooled results suggest no significant difference in mortality with EN compared with PN (odds ratio [OR] = 0.77; 95% CI, 0.56-1.05; I = 26%). Exclusion of the only study that reported an increase in mortality resulted in a borderline significant reduction in mortality with EN (OR = 0.71; 95% CI, 0.51-1.00; I = 26%). The predictors of EN were male sex, older age, heavier weight, greater height, cardiac diagnosis, longer duration of ECMO, and use of venovenous ECMO. Most studies suggest no correlation between EN and complications. EN use in children and adolescents who receive ECMO does not appear to be associated with increased mortality compared with PN and was safe in terms of intestinal complications and feeding intolerance.
肠内营养(EN)是接受体外膜肺氧合(ECMO)治疗的儿童和青少年的一种营养支持方法,但针对该人群,尚无使用 EN 的指南。我们进行了一项系统评价,以确定在接受 ECMO 支持的儿童中,EN 是否有效和安全。我们于 2023 年 3 月在 Cochrane 图书馆数据库、MEDLINE 和 Embase(Ovid)上搜索了评估接受 ECMO 并接受 EN 治疗的儿童和青少年的研究。使用随机效应荟萃分析来估计与肠外营养(PN)相比,EN 治疗的死亡率。本综述共纳入 14 项研究,共纳入 1650 例患者(796 例接受 EN)。ECMO 的中位持续时间为 5-10 天,EN 启动时间中位数范围为 23 小时至 7 天。汇总结果表明,EN 与 PN 相比,死亡率无显著差异(比值比[OR] = 0.77;95% CI,0.56-1.05;I = 26%)。排除唯一报告死亡率增加的研究后,EN 治疗的死亡率有显著降低趋势(OR = 0.71;95% CI,0.51-1.00;I = 26%)。EN 的预测因素包括男性、年龄较大、体重较重、身高较高、心脏诊断、ECMO 持续时间较长和使用静脉-静脉 ECMO。大多数研究表明,EN 与并发症之间无相关性。与 PN 相比,接受 ECMO 的儿童和青少年使用 EN 似乎不会增加死亡率,并且在肠道并发症和喂养不耐受方面是安全的。